Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | March 17, 2011 | March 18, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date March 17, 2011 · Filed March 18, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,000 |
Reported balance
After 2011-03-17 transaction · row 1
1 source rowRow 1 · 2011-03-17 · Sale · Disposed 2,000 · Balance 12,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2011 Filed Mar 18, 2011 16:53 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,000 | $44.62 | $89,240.00 |
DisclosureSEC source: 0001209191-11-018838 · doc4.xml · nonDerivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| June 01, 2010 Filed Jun 2, 2010 19:27 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $34.24 | $0.00 |
DisclosureSEC source: 0000875320-10-000028 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2020-05-31 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 11, 2010 Filed Feb 12, 2010 17:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 645 | $38.53 | $24,851.85 |
DisclosureSEC source: 0000875320-10-000012 · edgar.xml · nonDerivative · entry 2 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Read SEC document |
| February 11, 2010 Filed Feb 12, 2010 17:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 1,355 | $38.52 | $52,194.60 |
DisclosureSEC source: 0000875320-10-000012 · edgar.xml · nonDerivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,645 Read SEC document |
| June 12, 2009 Filed Jun 25, 2009 19:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,000 | $31.16 | $62,320.00 |
DisclosureSEC source: 0000875320-09-000049 · edgar.xml · nonDerivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:40 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000040 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fullly vested. Read SEC document |
| June 01, 2008 Filed Jun 2, 2008 20:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $28.40 | $0.00 |
DisclosureSEC source: 0000875320-08-000035 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2018-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2007 Filed Jun 4, 2007 16:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.84 | $0.00 |
DisclosureSEC source: 0000875320-07-000061 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2017-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2006 Filed Jun 2, 2006 17:11 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $34.32 | $0.00 |
DisclosureSEC source: 0000875320-06-000049 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 20,000 shares Expires 2016-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2005 Filed Jun 3, 2005 14:54 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0000875320-05-000026 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2015-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.